ve-panel 3b: community engagement and involvement in hiv vaccine prevention clinical research
Published 3 years ago • 987 plays • Length 1:02:07Download video MP4
Download video MP3
Similar videos
-
56:51
ve-panel 2b: future design approaches for hiv vaccine efficacy trials
-
57:54
ve panel 1: design approaches for current and future hiv prevention efficacy trials
-
57:36
ve-panel 3: novel scientific approaches to establish efficacy of new biologics for hiv prevention
-
58:40
ve-panel 2c: research pathway for the use of monoclonal antibodies in hiv prevention.
-
25:27
hivr4p // virtual sa03 hiv & tb: an r&d tale of two vaccines (part 1/3)
-
9:20
is the new hiv vaccine really effective?
-
1:28:31
accessing long-acting hiv prevention & treatment innovations: landscape, service delivery & pathways
-
7:37
viiv healthcare - here until hiv and aids are not
-
1:29:48
swinging into full gear: strengthening industry engagement in hiv vaccine research and development
-
1:31:30
africa hiv cure research: strengthening industry-community engagement in clinical research
-
1:29:06
webinar 02 – experimental medicine trials for hiv research
-
58:08
ve-panel 2a: future design approaches for settings where all participants are on active prevention
-
19:38
hivr4p // virtual 2021 (sa16) how hiv vaccine r&d is enabling the rapid covid-19 vaccine response
-
28:50
s3-04: evaluating an hiv vaccine efficacy vs. counterfactual placebo: immune mediator approach
-
23:37
w26052107 gene signature associating with hiv vaccine efficacy and antibody effector function
-
34:10
next-generation hiv prevention and therapy: antibody-based approaches
-
3:11:24
global hiv vaccine enterprise annual stakeholders meeting: accelerating early phase vaccine research
-
25:21
hivr4p // virtual sa03 hiv & tb: an r&d tale of two vaccines (part 2/3)
-
58:25
brown bag lunch: hiv vaccines: research & trends, may 2021
-
1:00:54
community engagement in hiv research: community leader insights, experiences, and best practices
-
1:15:35
challenges and opportunities on the access to future monoclonal antibodies for hiv prevention
-
53:24
perspectives on hiv cure research: clinical trial participation panel